168 related articles for article (PubMed ID: 24774036)
1. High levels of endothelial progenitor cells can be associated with thrombosis in patients with Behçet's disease.
Bozkirli ED; Keşkek SÖ; Kozanoğlu I; Yücel AE
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S49-53. PubMed ID: 24774036
[TBL] [Abstract][Full Text] [Related]
2. Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease.
Fadini GP; Tognon S; Rodriguez L; Boscaro E; Baesso I; Avogaro A; Semenzato G; Agostini C; Marcolongo R
Clin Exp Rheumatol; 2009; 27(5):814-21. PubMed ID: 19917165
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
5. High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity.
Arica DA; Akşan B; Örem A; Altinkaynak BA; Yayli S; Sönmez M
An Bras Dermatol; 2019 Jul; 94(3):320-326. PubMed ID: 31365661
[TBL] [Abstract][Full Text] [Related]
6. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of coagulation parameters and vessel involvement in Behcet' s disease. A clinical experience of Behcet' s disease: study of 152 cases.
Harman E; Sayarlıoglu M; Harman M; Sayarlıoglu H
Acta Med Iran; 2013 May; 51(4):215-23. PubMed ID: 23690099
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
9. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
[TBL] [Abstract][Full Text] [Related]
11. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
[TBL] [Abstract][Full Text] [Related]
12. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
13. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
14. High Levels of Circulating Endothelial Progenitor Cells Are Associated with Acrotism in Patients with Takayasu Arteritis.
Keşkek ŞÖ; Bozkırlı-Ersözlü ED; Kozanoglu I; Yücel AE
Med Princ Pract; 2017; 26(2):132-138. PubMed ID: 27816980
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
Balkarli A; Kucuk A; Babur H; Erbasan F
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
[TBL] [Abstract][Full Text] [Related]
17. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
[TBL] [Abstract][Full Text] [Related]
20. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
